Intraaortic balloon pumping in cardiac surgical patients: a nine-year experience.

D. Pennington,M. Swartz,J. Codd,J. Merjavy,G. Kaiser

DOI: https://doi.org/10.1016/S0003-4975(10)60445-6

1983-08-01

Abstract:

What problem does this paper attempt to address?

Optimizing of a suitable protocol for isolating tissue-derived extracellular vesicles and profiling small RNA patterns in hepatocellular carcinoma

Wenjing Yang,Yu Liu,Jiyan Wang,Te Liu,Tongtong Tian,Tong Li,Lin Ding,Wei Chen,Hao Wang,Jie Zhu,Chunyan Zhang,Baishen Pan,Jian Zhou,Jia Fan,Beili Wang,XinRong Yang,Wei Guo

DOI: https://doi.org/10.1111/liv.16011

Abstract:Background: Extracellular vesicles (EVs) facilitate cell-cell interactions in the tumour microenvironment. However, standard and efficient methods to isolate tumour tissue-derived EVs are lacking, and their biological functions remain elusive. Methods: To determine the optimal method for isolating tissue-derived EVs, we compared the characterization and concentration of EVs obtained by three previously reported methods using transmission electron microscopy, nanoparticle tracking analysis, and nanoflow analysis (Nanoflow). Additionally, the differential content of small RNAs, especially tsRNAs, between hepatocellular carcinoma (HCC) and adjacent normal liver tissues (ANLTs)-derived EVs was identified using Arraystar small RNA microarray. The targets of miRNAs and tsRNAs were predicted, and downstream functional analysis was conducted using Gene Ontology, Kyoto Encyclopedia of Genes and Genomes, non-negative matrix factorization and survival prediction analysis. Results: A differential centrifugation-based protocol without cell cultivation (NC protocol) yielded higher EV particles and higher levels of CD9+ and CD63+ EVs compared with other isolation protocols. Interestingly, the NC protocol was also effective for isolating frozen tissue-derived EVs that were indistinguishable from fresh tissue. HCC tissues showed significantly higher EV numbers compared with ANLTs. Furthermore, we identified different types of small RNAs in HCC tissue-derived EVs, forming a unique multidimensional intercellular communication landscape that can differentiate between HCC and ANLTs. ROC analysis further showed that the combination of the top 10 upregulated small RNAs achieved better diagnostic performance (AUC = .950 [.895-1.000]). Importantly, most tsRNAs in HCC tissue-derived EVs were downregulated and mitochondria-derived, mainly involving in lipid-related metabolic reprogramming. Conclusion: The NC protocol was optimal for isolating EVs from HCC, especially from frozen tissues. Our study emphasized the different roles of small-RNA in regulating the HCC ecosystem, providing insights into HCC progression and potential therapeutic targets.
Selective Enrichment and Detection of PD-L1 Positive Extracellular Vesicles Derived from Human Plasma and Patient Derived Tumor Cells

Yongan Ren,Ke Ge,Wei Lu,Wenbo Peng,Haiyan Che,Jianxin Ma,Changku Jia,Bo Yao

DOI: https://doi.org/10.1016/j.snb.2022.133086

2023-01-01

Abstract:Recent studies reported that the level of PD-L1 carried by extracellular vesicles (EVs) could distinguish the presence of tumors and had a good correlation with the response to immunotherapy. In this manuscript, we developed an EV-TdT assay for isolation and detection of PD-L1+ EVs. PD-L1+ EVs were directly captured from biological samples by PD-L1 antibodies immobilized on the magnetic beads (MBs), then combined with cholesterol modified DNA probes, which initiated the terminal deoxynucleotidyl transferase (TdT) to amplify the signal of PD-L1+ EVs. The EV-TdT assay enables selective enrichment of PD-L1+ EVs in low-content samples, such as blood and excreta of small amounts of primary tumor cells. Moreover, it can evaluate the relative abundance of PD-L1+ EVs in the total population, by this way, we observed that PD-L1+ EVs were more abundant in the extracellular microenvironment of primary tumor cells than in human plasma, indicating that quite a bit of PD-L1+ EVs were derived from tumor cells. The EV-TdT assay has been proven a practical method for detection of PD-L1+ EVs and is greatly potential as an alternative to existing assays for screening immunotherapy benefit populations.
Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring

Na Sun,Yi-Te Lee,Ryan Y. Zhang,Rueihung Kao,Pai-Chi Teng,Yingying Yang,Peng Yang,Jasmine J. Wang,Matthew Smalley,Pin-Jung Chen,Minhyung Kim,Shih-Jie Chou,Lirong Bao,Jing Wang,Xinyue Zhang,Dongping Qi,Juvelyn Palomique,Nicolas Nissen,Steven-Huy B. Han,Saeed Sadeghi,Richard S. Finn,Sammy Saab,Ronald W. Busuttil,Daniela Markovic,David Elashoff,Hsiao-hua Yu,Huiying Li,Anthony P. Heaney,Edwin Posadas,Sungyong You,Ju Dong Yang,Renjun Pei,Vatche G. Agopian,Hsian-Rong Tseng,Yazhen Zhu

DOI: https://doi.org/10.1038/s41467-020-18311-0

IF: 16.6

2020-09-07

Nature Communications

Abstract:Abstract We report a covalent chemistry-based hepatocellular carcinoma (HCC)-specific extracellular vesicle (EV) purification system for early detection of HCC by performing digital scoring on the purified EVs. Earlier detection of HCC creates more opportunities for curative therapeutic interventions. EVs are present in circulation at relatively early stages of disease, providing potential opportunities for HCC early detection. We develop an HCC EV purification system (i.e., EV Click Chips) by synergistically integrating covalent chemistry-mediated EV capture/release, multimarker antibody cocktails, nanostructured substrates, and microfluidic chaotic mixers. We then explore the translational potential of EV Click Chips using 158 plasma samples of HCC patients and control cohorts. The purified HCC EVs are subjected to reverse-transcription droplet digital PCR for quantification of 10 HCC-specific mRNA markers and computation of digital scoring. The HCC EV-derived molecular signatures exhibit great potential for noninvasive early detection of HCC from at-risk cirrhotic patients with an area under receiver operator characteristic curve of 0.93 (95% CI, 0.86 to 1.00; sensitivity = 94.4%, specificity = 88.5%).

multidisciplinary sciences
Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

David Eun Reynolds,George Galanis,Yongcheng Wang,Jina Ko

DOI: https://doi.org/10.1007/978-1-0716-3323-6_16

2023-01-01

Abstract:Extracellular vesicles (EVs) are lipid-bound nanometer-sized vesicles released by all cell types that contain molecular payload such as proteins and/or nucleic acids. EVs are a key facet of cell-to-cell communication and have the potential to be used in the diagnosis of numerous diseases, chief among them being cancer. However, most methods of EV analysis struggle to identify the rare, malformed proteins indicative of tumor cells as tumor EVs represent only a tiny fraction of the bulk EVs present in the bloodstream. Here, we present a method of single EV analysis, utilizing droplet microfluidics to encapsulate EVs, which are labeled with DNA barcodes linked to antibodies, in droplets with the DNA extension used to amplify the signals associated with each EV. The amplified DNA can then be sequenced to assess the protein content of individual EVs, enabling the detection of rare proteins and EV subpopulations within a bulk EV sample.
A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis

Ali Riza Koksal,Nergiz Ekmen,Yucel Aydin,Kelley Nunez,Tyler Sandow,Molly Delk,Martin Moehlen,Paul Thevenot,Ari Cohen,Srikanta Dash

DOI: https://doi.org/10.2147/JHC.S423043

2023-11-02

Abstract:Introduction: Extracellular vesicles could serve as a non-invasive biomarker for early cancer detection. However, limited methods to quantitate cancer-derived vesicles in the native state remain a significant barrier to clinical translation. Aim: This research aims to develop a rapid, one-step immunoaffinity approach to quantify HCC exosomes directly from a small serum volume. Methods: HCC-derived exosomes in the serum were captured using fluorescent phycoerythrin (PE)-conjugated antibodies targeted to GPC3 and alpha-fetoprotein (AFP). Total and HCC-specific exosomes were then quantified in culture supernatant or patient-derived serums using fluorescence nanoparticle tracking analysis (F-NTA). The performance of HCC exosome quantification in the serum was compared with the tumor size determined by MRI. Results: Initially we tested the detection limits of the F-NTA using synthetic fluorescent and non-fluorescent beads. The assay showed an acceptable sensitivity with a detection range of 104-108 particles/mL. Additionally, the combination of immunocapture followed by size-exclusion column purification allows the isolation of smaller-size EVs and quantification by F-NTA. Our assay demonstrated that HCC cell culture releases a significantly higher quantity of GPC3 or GPC3+AFP positive EVs (100-200 particles/cell) compared to non-HCC culture (10-40 particles/cell) (p<0.01 and p<0.05 respectively). The F-NTA enables absolute counting of HCC-specific exosomes in the clinical samples with preserved biological immunoreactivity. The performance of F-NTA was clinically validated in serum from patients ± cirrhosis and with confirmed HCC. F-NTA quantification data show selective enrichment of AFP and GPC3 positive EVs in HCC serum compared to malignancy-free cirrhosis (AUC values for GPC3, AFP, and GPC3/AFP were found 0.79, 0.71, and 0.72 respectively). The MRI-confirmed patient cohort indicated that there was a positive correlation between total tumor size and GPC3-positive exosome concentration (r:0.78 and p<0.001). Conclusion: We developed an immunocapture assay that can be used for simultaneous isolation and quantification of HCC-derived exosomes from a small serum volume with high accuracy.
Molecular Identification of Tumor-Derived Extracellular Vesicles Using Thermophoresis-Mediated DNA Computation

Yike Li,Jinqi Deng,Ziwei Han,Chao Liu,Fei Tian,Rui Xu,Da Han,Shaohua Zhang,Jiashu Sun

DOI: https://doi.org/10.1021/jacs.0c12016

IF: 15

2021-01-18

Journal of the American Chemical Society

Abstract:Molecular profiling of tumor-derived extracellular vesicles (tEVs) holds great promise for non-invasive cancer diagnosis. However, sensitive and accurate identification of tEVs is challenged by the heterogeneity of EV phenotypes which reflect different cell origins. Here we present a DNA computation device mediated by thermophoresis for detection of tEVs. The strategy leverages the aptamer-based logic gate using multiple protein biomarkers on single EVs as the input and thermophoretic accumulation to amplify the output signals for highly sensitive and specific profiling of tEVs. Employing this platform, we demonstrate a high accuracy of 97% for discrimination of breast cancer (BC) patients and healthy donors in a clinical cohort (<i>n</i> = 30). Furthermore, molecular phenotyping assessed by tEVs is in concordance with the results from tissue biopsy in BC patients. The thermophoresis-mediated molecular computation on EVs thus provides new opportunities for accurate detection and classification of cancers.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/jacs.0c12016?goto=supporting-info">https://pubs.acs.org/doi/10.1021/jacs.0c12016</a>.Experimental methods, additional discussion, Tables S1–S3, and Figures S1–S18 (<a class="ext-link" href="/doi/suppl/10.1021/jacs.0c12016/suppl_file/ja0c12016_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

chemistry, multidisciplinary
Ultrasensitive and Wash-Free Detection of Tumor Extracellular Vesicles by Aptamer-Proximity-Ligation-Activated Rolling Circle Amplification Coupled to Single Particle ICP-MS

Xue-Wei Zhang,Gong-Xiang Qi,Shuai Chen,Yong-Liang Yu,Jian-Hua Wang

DOI: https://doi.org/10.1021/acs.analchem.4c02066

IF: 7.4

2024-06-22

Analytical Chemistry

Abstract:Tumor-derived extracellular vesicles (TEVs) are rich in cellular information and hold great promise as a biomarker for noninvasive cancer diagnosis. However, accurate measurement of TEVs presents challenges due to their low abundance and potential interference from a high number of EVs derived from normal cells. Herein, an aptamer-proximity-ligation-activated rolling circle amplification (RCA) method for EV membrane recognition, coupled with single particle inductively coupled plasma mass...

chemistry, analytical
Digital Profiling of Tumor Extracellular Vesicle-associated RNAs Directly from Unprocessed Blood Plasma

Elizabeth Maria Clarissa,Sumit Kumar,Juhee Park,Mamata Karmacharya,In-Jae Oh,Mi-Hyun Kim,Jeong-Seon Ryu,Yoon-Kyoung Cho

DOI: https://doi.org/10.1101/2024.05.06.592543

2024-05-09

Abstract:Tumor-derived extracellular vesicle (tEV)-associated RNAs hold promise as diagnostic biomarkers, but their clinical use is hindered by the rarity of tEVs among non-tumor EVs. Here, we present EV-CLIP, a highly sensitive droplet-based digital method for profiling EV RNA. EV-CLIP utilizes the fusion of EVs with charged liposomes (CLIPs) in a microfluidic chip. Optimized CLIP surface charge enables exceptional sensitivity and selectivity for EV-derived miRNAs and mRNAs. This approach streamlines detection with minimal plasma volume (20 µL) and eliminates the need for prior EV isolation or RNA preparation, preventing loss of EVs or RNA. In testing with 83 patient samples, EV-CLIP detected EGFR L858R and T790M mutations with high AUC values of 1.0000 and 0.9784, respectively. Its success in serial monitoring during chemotherapy highlights its potential for precise quantification of rare EV subpopulations, facilitating the exploration of single EV RNA content and enhancing understanding of diverse EV populations in various disease states.

Bioengineering
Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer

Jiantong Dong,Ryan Y. Zhang,Na Sun,Matthew Smalley,Zipeng Wu,Anqi Zhou,Shih-Jie Chou,Yu Jen Jan,Peng Yang,Lirong Bao,Dongping Qi,Xinghong Tang,Patrick Tseng,Yue Hua,Dianwen Xu,Rueihung Kao,Meng,Xirun Zheng,Ying Liu,Tatyana Vagner,Xiaoshu Chai,Dongjing Zhou,Mengyuan Li,Shih-Hwa Chiou,Guangjuan Zheng,Dolores Di Vizio,Vatche G. Agopian,Edwin Posadas,Steven J. Jonas,Shin-Pon Ju,Paul S. Weiss,Meiping Zhao,Hsian-Rong Tseng,Yazhen Zhu

DOI: https://doi.org/10.1021/acsami.9b01406

IF: 9.5

2019-01-01

ACS Applied Materials & Interfaces

Abstract:Tumor-derived extracellular vesicles (EVs) present in bodily fluids are emerging liquid biopsy markers for non-invasive cancer diagnosis and treatment monitoring. Because the majority of EVs in circulation are not of tumor origin, it is critical to develop new platforms capable of enriching tumor-derived EVs from the blood. Herein, we introduce a biostructure-inspired NanoVilli Chip, capable of highly efficient and reproducible immunoaffinity capture of tumor-derived EVs from blood plasma samples. Anti-EpCAMgrafted silicon nanowire arrays were engineered to mimic the distinctive structures of intestinal microvilli, dramatically increasing surface area and enhancing tumor-derived EV capture. RNA in the captured EVs can be recovered for downstream molecular analyses by reverse transcription Droplet Digital PCR. We demonstrate that this assay can be applied to monitor the dynamic changes of ROS1 rearrangements and epidermal growth factor receptor T790M mutations that predict treatment responses and disease progression in non -small cell lung cancer patients.
Localized fluorescent imaging of multiple proteins on individual extracellular vesicles using rolling circle amplification for cancer diagnosis

Junli Zhang,Jinjin Shi,Hongling Zhang,Yifan Zhu,Wei Liu,Kaixiang Zhang,Zhenzhong Zhang

DOI: https://doi.org/10.1002/jev2.12025

2020-11-01

Journal of Extracellular Vesicles

Abstract:Extracellular vesicles (EV) have attracted increasing attention as tumour biomarkers due to their unique biological property. However, conventional methods for EV analysis are mainly based on bulk measurements, which masks the EV-to-EV heterogeneity in tumour diagnosis and classification. Herein, a localized fluorescent imaging method (termed Digital Profiling of Proteins on Individual EV, DPPIE) was developed for analysis of multiple proteins on individual EV. In this assay, an anti-CD9 antibody engineered biochip was used to capture EV from clinical plasma sample. Then the captured EV was specifically recognized by multiple DNA aptamers (CD63/EpCAM/MUC1), followed by rolling circle amplification to generate localized fluorescent signals. By-analyzing the heterogeneity of individual EV, we found that the high-dimensional data collected from each individual EV would provide more precise information than bulk measurement (ELISA) and the percent of CD63/EpCAM/MUC1-triple-positive EV in breast cancer patients was significantly higher than that of healthy donors, and this method can achieve an overall accuracy of 91%. Moreover, using DPPIE, we are able to distinguish the EV between lung adenocarcinoma and lung squamous carcinoma patients. This individual EV heterogeneity analysis strategy provides a new way for digging more information on EV to achieve multi-cancer diagnosis and classification.

cell biology
Simultaneous detection of membrane protein and mRNA at single extracellular vesicle level by droplet microfluidics for cancer diagnosis

Huixian Lin,Bo Li,Jingyun Guo,Xueying Mai,Haiyang Yu,Weilun Pan,Bodeng Wu,Wei Liu,Mingzhen Zhong,Tong Liao,Ye Zhang,Bo Situ,Xiaohui Yan,Yifan Liu,Chunchen Liu,Lei Zheng

DOI: https://doi.org/10.1016/j.jare.2024.08.026

2024-08-26

Abstract:Introduction: Simultaneous detection of proteins and mRNA within a single extracellular vesicle (EV) enables comprehensive analysis of specific EVs subpopulations, significantly advancing cancer diagnostics. However, developing a sensitive and user-friendly approach for simultaneously detecting multidimensional biomarkers in single EV is still challenging. Objectives: To facilitate the analysis of multidimensional biomarkers in EVs and boost its clinical application, we present a versatile droplet digital system facilitating the concurrent detection of membrane proteins and mRNA at the single EV level with high sensitivity and specificity. Methods: The antibody-DNA conjugates were firstly prepared for EVs protein biomarkers recognition and signal transformation. Coupling with the assembled triplex droplet digital PCR system, a versatile droplet digital analysis assay for simultaneous detection of membrane protein and mRNA at a single EV level was developed. Results: Our new droplet digital system displayed high sensitivity and specificity. Additionally, its clinical application was validated in a breast cancer cohort. As expected, this assay has demonstrated superior performance in distinguishing breast cancer from healthy individuals and benign controls through combined detection of EVs protein and mRNA markers compared to any single kind marker detections, especially for patients with breast cancer at early stage (AUC=0.9229). Conclusion: Consequently, this study proposes a promising strategy for accurately identifying and analyzing specific EV subgroups through the co-detection of proteins and mRNA at the single EV level, holding significant potential for future clinical applications.
Cascaded microfluidic circuits for pulsatile filtration of extracellular vesicles from whole blood for early cancer diagnosis

Zhenglin Li,Chao Liu,Yangchang Cheng,Yike Li,Jinqi Deng,Lixiao Bai,Lili Qin,Huili Mei,Min Zeng,Fei Tian,Shaohua Zhang,Jiashu Sun

DOI: https://doi.org/10.1126/sciadv.ade2819

IF: 13.6

2023-05-12

Science Advances

Abstract:Tumor-derived extracellular vesicles (EVs) hold the potential to substantially improve noninvasive early diagnosis of cancer. However, analysis of nanosized EVs in blood samples has been hampered by lack of effective, rapid, and standardized methods for isolating and detecting EVs. To address this difficulty, here we use the electric-hydraulic analogy to design cascaded microfluidic circuits for pulsatile filtration of EVs via integration of a cell-removal circuit and an EV-isolation circuit. The microfluidic device is solely driven by a pneumatic clock pulse generator, allowing for preprogrammed, clog-free, gentle, high-yield, and high-purity isolation of EVs directly from blood within 30 minutes. We demonstrate its clinical utility by detecting protein markers of isolated EVs from patient blood using a polyethylene glycol–enhanced thermophoretic aptasensor, with 91% accuracy for diagnosis of early-stage breast cancer. The cascaded microfluidic circuits can have broad applications in the field of EV research.

multidisciplinary sciences
CRISPR-based dual-aptamer proximity ligation coupled hybridization chain reaction for precise detection of tumor extracellular vesicles and cancer diagnosis

Shi-Fan Song,Xue-Wei Zhang,Shuai Chen,Yang Shu,Yong-Liang Yu,Jian-Hua Wang

DOI: https://doi.org/10.1016/j.talanta.2024.126780

IF: 6.1

2024-08-30

Talanta

Abstract:Tumor cell-derived extracellular vesicles (TEVs) contain numerous cellular molecules and are considered potential biomarkers for non-invasive liquid biopsy. However, due to the low abundance of TEVs secreted by tumor cells and their phenotypic heterogeneity, there is a lack of sensitive and specific methods to quantify TEVs. Here, we developed a dual-aptamer proximity ligation-coupled hybridization chain reaction (HCR) method for tracing TEVs, exploiting CRISPR to achieve highly sensitive detection. Taking advantage of the high binding affinity of aptamers, the two aptamers (Apt EpCAM , Apt HER2 ) exhibited the high selectivity for TEVs recognition. HCR generated long-repeated sequence containing multiple crRNA targetable barcodes, and the signals were further amplified by CRISPR upon recognizing the HCR sequences, thereby enhancing the sensitivity. Under optimal conditions, the developed method demonstrated a favorable linear relationship in the range of 2 × 10 3 −10 7 particles/μL, with a limit of detection (LOD) of 3.3 × 10 2 particles/μL. We directly applied our assay to clinical plasma analysis, achieving 100 % accuracy in cancer diagnosis, thus demonstrating the potential clinical applications of TEVs. Due to its simplicity and rapidity, excellent sensitivity and specificity, this method has broad applications in clinical medicine.

chemistry, analytical
Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma

Mazen A. Juratli,Nicola S. Pollmann,Elsie Oppermann,Annika Mohr,Dhruvajyoti Roy,Andreas Schnitzbauer,Sabine Michalik,Thomas Vogl,Nikolas H. Stoecklein,Philipp Houben,Shadi Katou,Felix Becker,Jens Peter Hoelzen,Andreas Andreou,Andreas Pascher,Wolf O. Bechstein,Benjamin Struecker

DOI: https://doi.org/10.1038/s41598-024-55888-8

IF: 4.6

2024-03-06

Scientific Reports

Abstract:Hepatocellular carcinoma (HCC) is the most common primary malignant liver tumor and a leading cause of cancer-related deaths worldwide. However, current diagnostic tools are often invasive and technically limited. In the last decade, non-invasive liquid biopsies have transformed the field of clinical oncology, showcasing the potential of various liquid-biopsy derived analytes, including extracellular vesicles (EVs), to diagnose and monitor HCC progression and metastatic spreading, serving as promising novel biomarkers. A prospective single-center cohort study including 37 HCC patients and 20 patients with non-malignant liver disease (NMLD), as a control group, was conducted. Serum EVs of both groups were analyzed before and after liver surgery. The study utilized microbead-based magnetic particle sorting and flow cytometry to detect 37 characteristic surface proteins of EVs. Furthermore, HCC patients who experienced tumor recurrence (R-HCC) within 12 months after surgery were compared to HCC patients without recurrence (NR-HCC). EVs of R-HCC patients (n = 12/20) showed significantly lower levels of CD31 compared to EVs of NR-HCC patients ( p = 0.0033). EVs of NMLD-group showed significantly higher expressions of CD41b than EVs of HCC group ( p = 0.0286). The study determined significant short-term changes in CD19 dynamics in EVs of the NMLD-group, with preoperative values being significantly higher than postoperative values ( p = 0.0065). This finding of our pilot study suggests EVs could play a role as potential targets for the development of diagnostic and therapeutic approaches for the early and non-invasive detection of HCC recurrence. Further, more in-depth analysis of the specific EV markers are needed to corroborate their potential role as diagnostic and therapeutic targets for HCC.

multidisciplinary sciences
Profiling of single-vesicle surface proteins via droplet digital immuno-PCR for multi-subpopulation extracellular vesicles counting towards cancer diagnostics

Chunchen Liu,Huixian Lin,Jingyun Guo,Chao Yang,Jing Chen,Weilun Pan,Binbin Cui,Junjie Feng,Ye Zhang,Bo Li,Shuhuai Yao,Lei Zheng

DOI: https://doi.org/10.1016/j.cej.2023.144364

IF: 15.1

2023-06-01

Chemical Engineering Journal

Abstract:Quantification of protein-specific extracellular vesicle (EV) subpopulations at the single-vesicle level is of great significance for cancer diagnosis. Although individual vesicle analysis has been implemented by novel emerging technologies, developing an easy-to-operate and cost-effective single EV analysis approach to promote clinical applications is still challenging. Herein, we constructed a versatile droplet digital immuno-PCR (ddiPCR) assay which integrates the high specificity of immuno-PCR and superior sensitivity of droplet digital PCR to profile the surface proteins of single EVs for multi-subpopulation EVs counting. The clinical application of the ddiPCR assay was validated by simultaneous profiling the EV proteins of CD9/CD63/CD81, HER2, EpCAM in a breast cancer cohort, and CD9/CD63/CD81, GPC-3, EpCAM in a hepatocellular carcinoma cohort (HCC). The results demonstrated that the counting of multi-subpopulation EVs could significantly distinguish patients with breast tumor or HCC from healthy controls. Furthermore, with the assistance of machine learning algorithm and under the best combination of sEV subpopulations, our method exhibited great performance in differentiating breast cancer from healthy individuals. Therefore, this study provides a promising strategy to count multi-subpopulation EVs at the single-vesicle level for cancer diagnosis.

engineering, chemical, environmental
Isolation and Detection Technologies of Extracellular Vesicles and Application on Cancer Diagnostic

Chunyan Ma,Fan Jiang,Yifan Ma,Jinqiao Wang,Hongjuan Li,Jingjing Zhang

DOI: https://doi.org/10.1177/1559325819891004

2019-10-01

Abstract:The vast majority of cancers are treatable when diagnosed early. However, due to the elusive trace and the limitation of traditional biopsies, most cancers have already spread widely and are at advanced stages when they are first diagnosed, causing ever-increasing mortality in the past decades. Hence, developing reliable methods for early detection and diagnosis of cancer is indispensable. Recently, extracellular vesicles (EVs), as circulating phospholipid vesicles secreted by cells, are found to play significant roles in the intercellular communication as well as the setup of tumor microenvironments and have been identified as one of the key factors in the next-generation technique for cancer diagnosis. However, EVs present in complex biofluids that contain various contaminations such as nonvesicle proteins and nonspecific EVs, resulting in the interference of screening for desired biomarkers. Therefore, applicable isolation and enrichment methods that guarantee scale-up of sample volume, purity, speed, yield, and tumor specificity are necessary. In this review, we introduce current technologies for EV separation and summarize biomarkers toward EV-based cancer liquid biopsy. In conclusion, a novel systematic isolation method that guarantees high purity, recovery rate, and tumor specificity is still missing. Besides that, a dual-model EV-based clinical trial system includes isolation and detection is a hot trend in the future due to efficient point-of-care needs. In addition, cancer-related biomarkers discovery and biomarker database establishment are essential objectives in the research field for diagnostic settings.

pharmacology & pharmacy,radiology, nuclear medicine & medical imaging
A smart TESTER for reliable discrimination of cancer-derived small extracellular vesicles

Ruyan Niu,Xiaohui Chen,Zixin Sun,Liu Wang,Zining Wang,Chong Zhang,Dan Ding,Jichun Yang,Yongzhong Wang,Yang Luo

DOI: https://doi.org/10.1016/j.aca.2023.341636

IF: 6.911

2023-07-18

Analytica Chimica Acta

Abstract:Cancer-derived small extracellular vesicles (csEVs) are crucial liquid biopsy indicators that reflect the presence and progression of many malignancies. However, reliable discrimination of csEVs remains a great challenge owing to the interference from normal sEVs (nsEVs) and low abundance in the early stages of cancer. In this work, we developed a Two-Elements Selectively Triggered csEVs Recognization (TESTER) strategy for selective identification of csEVs from the complex clinical body fluid samples. This method was based on the MNAzyme-controlled synchronous recognition to EpCAM and CD63 proteins on the membrane of csEVs. Efficient recognition to csEVs via EpCAM aptamer and CD63 aptamer prompted the release of Partzyme A and Partzyme B probes to induce a MNAzyme structure formation, resulting in the cyclic cleavage of substrate chain to produce cascade fluorescence signal amplification. The detection threshold of the developed TESTER approach for csEVs in complicated biological samples was 72 particles μL −1 , accomplishing the highly sensitive and selective quantification of csEVs. At the same time, we successfully constructed a new platform for bimolecular simultaneous recognition, which provides a good idea for the construction of bimolecular-activated detection switch in the future.

chemistry, analytical
Isolation and characterization of osmotic stress-induced genes in poplar cells by suppression subtractive hybridization and cDNA microarray analysis.

E. Bae,Hyoshin Lee,Jae-Soon Lee,E. Noh

DOI: https://doi.org/10.1016/j.plaphy.2009.11.002

2010-02-01

Abstract:
Ultrasensitive determination of surface proteins on tumor-derived small extracellular vesicles for breast cancer identification based on lanthanide-activated signal amplification strategy

Shasha Cheng,Cuiling Zhang,Xinyu Hu,Yingxin Zhu,Hui Shi,Wenqiao Tan,Xianzhu Luo,Yuezhong Xian

DOI: https://doi.org/10.1016/j.talanta.2023.125189

IF: 6.1

2023-09-13

Talanta

Abstract:Small extracellular vesicles (sEVs) carrying multiple tumor-associated proteins inherited from parental cells play crucial roles in noninvasive breast cancer (BC) diagnosis. However, it is challenging to assess the subtle variations of surface proteins on sEV membranes due to the highly heterogeneous BC. Therefore, a simple and ultrasensitive assay based on lanthanide (Ln 3+ )-activated luminescence signal amplification was developed to detect multiple surface proteins on BC-derived sEVs. Multiple protein biomarkers on sEVs can be well identified with high sensitivity and specificity through dissolution-amplified luminescence of the NaEuF 4 nanoparticle-based nanoprobe. We employ linear discriminant analysis to successfully discriminate triple negative BC cell (MDA-MB-231 cell) derived sEVs from other breast cell lines (MCF-7, SK-BR-3, BT474 and MCF-10A cell). Furthermore, the strategy enables high accuracy for districting the progression stages of BC patients and healthy donors. The simple and sensitive signal amplification strategy exhibits great potential for early clinic diagnosis by precise protein profiling of sEVs.

chemistry, analytical
The Mag-Click-Capture-Release Technology for Selective Capture and Release of Hepatocyte-Derived Extracellular Vesicles as Biomarkers for Liver Disease

Richell Booijink,Anouk Mentink,Larissa Jansen,Sven Mentink,Bo van Rein,Lieke Geraets,Jorinde Scholten,Maureen Brusse,Siyu Fu,Andre Boonstra,Ruchi Bansal

DOI: https://doi.org/10.1101/2024.10.25.620223

2024-10-25

Abstract:Chronic liver diseases, such as liver cirrhosis and hepatocellular carcinoma (HCC), present major global health challenges, often diagnosed late. Circulating extracellular vesicles (EVs), which carry disease-specific biomolecular cargo, is emerging as an early diagnostic and prognostic biomarker for several diseases including cancer. However, current EV purification methods including ultracentrifugation and size exclusion chromatography present several limitations. Here, we present the Mag-Click-Capture-Release Technology for selective capture and release of EVs that combines magnetic beads, trans-cyclooctene (TCO) and tetrazine (Tz) click chemistry, immuno(antibody)-based capture and disulfide-driven release of EVs. Importantly, the Mag-Click-Capture-Release Technology is customizable, whereby using specific antibodies conjugated to TCO antibodies, different EV subtypes can be selectively captured and released for further analysis. With our Mag-Click-Capture-Release Technology, we successfully isolated hepatocyte-derived EVs from human serum with good recovery, high specificity and purity when compared with standard ultracentrifugation. Validation in serum samples obtained from cirrhosis and HCC patients with alcohol-associated liver disease evidenced an increasing trend in hepatocyte-EV levels correlating with disease severity, suggesting potential for early diagnosis and prognosis. In conclusion, we present here the Mag-Click-Capture-Release Technology, a customizable and efficient approach for selective isolation of organ-, cell-specific, and disease-relevant EVs from biological samples that can be subsequently released for downstream molecular EV analysis and EV-related functional assays.

Bioengineering

Intraaortic balloon pumping in cardiac surgical patients: a nine-year experience.

Optimizing of a suitable protocol for isolating tissue-derived extracellular vesicles and profiling small RNA patterns in hepatocellular carcinoma

Selective Enrichment and Detection of PD-L1 Positive Extracellular Vesicles Derived from Human Plasma and Patient Derived Tumor Cells

Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring

Single Extracellular Vesicle Analysis Using Droplet Microfluidics.

A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis

Molecular Identification of Tumor-Derived Extracellular Vesicles Using Thermophoresis-Mediated DNA Computation

Ultrasensitive and Wash-Free Detection of Tumor Extracellular Vesicles by Aptamer-Proximity-Ligation-Activated Rolling Circle Amplification Coupled to Single Particle ICP-MS

Digital Profiling of Tumor Extracellular Vesicle-associated RNAs Directly from Unprocessed Blood Plasma

Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer

Localized fluorescent imaging of multiple proteins on individual extracellular vesicles using rolling circle amplification for cancer diagnosis

Simultaneous detection of membrane protein and mRNA at single extracellular vesicle level by droplet microfluidics for cancer diagnosis

Cascaded microfluidic circuits for pulsatile filtration of extracellular vesicles from whole blood for early cancer diagnosis

CRISPR-based dual-aptamer proximity ligation coupled hybridization chain reaction for precise detection of tumor extracellular vesicles and cancer diagnosis

Extracellular vesicles as potential biomarkers for diagnosis and recurrence detection of hepatocellular carcinoma

Profiling of single-vesicle surface proteins via droplet digital immuno-PCR for multi-subpopulation extracellular vesicles counting towards cancer diagnostics

Isolation and Detection Technologies of Extracellular Vesicles and Application on Cancer Diagnostic

A smart TESTER for reliable discrimination of cancer-derived small extracellular vesicles

Isolation and characterization of osmotic stress-induced genes in poplar cells by suppression subtractive hybridization and cDNA microarray analysis.

Ultrasensitive determination of surface proteins on tumor-derived small extracellular vesicles for breast cancer identification based on lanthanide-activated signal amplification strategy

The Mag-Click-Capture-Release Technology for Selective Capture and Release of Hepatocyte-Derived Extracellular Vesicles as Biomarkers for Liver Disease